Key Ovarian Antibodies

Ovarian Cancer Antibodies

Ovarian Cancer

Ovarian cancers are a relatively rare diagnosed cancer in the United States, with about 1.3% of new cancer cases classified as ovarian yet contributing 2.4% of cancer deaths yearly. As of 2011, there were approximately 189,000 women living with ovarian cancer in the United States. Those diagnosed with ovarian cancer have a 5 year survival rate of 44.6%. Over the last 10 years, both the new cancer case rate and the death rate have dropped 1.1% and 2.0% per year, respectively. Biocare Medical is proud to offer key ovarian antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.

SEER Cancer Statistics Factsheets: Ovary Cancer. National Cancer Institute. Bethesda, MD,

Biocare Clone

PAX8 (M)


Biocare Clone

Inhibin, Alpha


Biocare Clone

Cytokeratin 7